Sramana Mitra: What have you been up to in the field of medical imaging? What are you learning? What insights can we convey here?
Sramana Mitra: Could you talk a little bit about the financing journey of a company that has a 10-15 year lifecycle?
Sramana Mitra: So let’s double click down on drug discovery. It’s something that I’ve been spending time on as well. What have you invested in and how are you thinking about AI-enabled drug discovery? What’s the criteria of what you want to invest in and what have you invested in?
Mo Islam, Partner at Threshold Ventures. discusses his firm’s AI investment thesis. We had an excellent discussion on AI-enabled drug discovery, AI-enabled medical imaging, etc.
Mo Islam, Partner at Threshold Ventures. discusses his firm’s AI investment thesis. We had an excellent discussion on AI-enabled drug discovery, AI-enabled medical imaging, etc.